Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Ticker SymbolBBLGW
CompanyBone Biologics Corp
CEOMr. Jeffrey Frelick
Websitehttps://www.bonebiologics.com/
FAQs
What is the current price of Bone Biologics Corp (BBLGW)?
The current price of Bone Biologics Corp (BBLGW) is 9.000.
What is the symbol of Bone Biologics Corp?
The ticker symbol of Bone Biologics Corp is BBLGW.
What is the 52-week high of Bone Biologics Corp?
The 52-week high of Bone Biologics Corp is 7.740.
What is the 52-week low of Bone Biologics Corp?
The 52-week low of Bone Biologics Corp is 1.300.
What is the market capitalization of Bone Biologics Corp?
The market capitalization of Bone Biologics Corp is --.
What is the net income of Bone Biologics Corp?
The net income of Bone Biologics Corp is --.
Is Bone Biologics Corp (BBLGW) currently rated as Buy, Hold, or Sell?
According to analysts, Bone Biologics Corp (BBLGW) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLGW)?
The Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLGW) is --.